189 related articles for article (PubMed ID: 35706810)
1. Mechanism of HBV-positive liver cancer cell exosomal miR-142-3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression.
Hu Z; Zhang H; Liu W; Yin Y; Jiang J; Yan C; Wang Y; Li L
Transl Cancer Res; 2022 May; 11(5):1173-1187. PubMed ID: 35706810
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression.
Hu Z; Yin Y; Jiang J; Yan C; Wang Y; Wang D; Li L
J Gastrointest Oncol; 2022 Apr; 13(2):754-767. PubMed ID: 35557596
[TBL] [Abstract][Full Text] [Related]
3. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.
Li W; Xin X; Li X; Geng J; Sun Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):107585. PubMed ID: 34601333
[TBL] [Abstract][Full Text] [Related]
4. CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis.
Xu Q; Zhou L; Yang G; Meng F; Wan Y; Wang L; Zhang L
Cell Biol Int; 2020 Nov; 44(11):2344-2356. PubMed ID: 32808701
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miR-628-5p from M1 polarized macrophages hinders m6A modification of circFUT8 to suppress hepatocellular carcinoma progression.
Wang L; Yi X; Xiao X; Zheng Q; Ma L; Li B
Cell Mol Biol Lett; 2022 Dec; 27(1):106. PubMed ID: 36474147
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
8. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
[TBL] [Abstract][Full Text] [Related]
9. Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222/TFRC axis.
Zhang Q; Qu Y; Zhang Q; Li F; Li B; Li Z; Dong Y; Lu L; Cai X
Cell Biol Toxicol; 2023 Apr; 39(2):467-481. PubMed ID: 34978008
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow mesenchymal stem cell-derived exosomes protect podocytes from HBx-induced ferroptosis.
Yang X; Yu Y; Li B; Chen Y; Feng M; Hu Y; Jiang W
PeerJ; 2023; 11():e15314. PubMed ID: 37193022
[TBL] [Abstract][Full Text] [Related]
11. miR-29a-3p in Exosomes from Heme Oxygenase-1 Modified Bone Marrow Mesenchymal Stem Cells Alleviates Steatotic Liver Ischemia-Reperfusion Injury in Rats by Suppressing Ferroptosis via Iron Responsive Element Binding Protein 2.
Li X; Wu L; Tian X; Zheng W; Yuan M; Tian X; Zuo H; Song H; Shen Z
Oxid Med Cell Longev; 2022; 2022():6520789. PubMed ID: 35720183
[TBL] [Abstract][Full Text] [Related]
12. M1 Macrophage-Derived Exosomal MicroRNA-326 Suppresses Hepatocellular Carcinoma Cell Progression Via Mediating NF-κB Signaling Pathway.
Bai ZZ; Li HY; Li CH; Sheng CL; Zhao XN
Nanoscale Res Lett; 2020 Dec; 15(1):221. PubMed ID: 33263825
[TBL] [Abstract][Full Text] [Related]
13. M2 macrophages-derived exosomal microRNA-501-3p promotes the progression of lung cancer via targeting WD repeat domain 82.
Lei J; Chen P; Zhang F; Zhang N; Zhu J; Wang X; Jiang T
Cancer Cell Int; 2021 Feb; 21(1):91. PubMed ID: 33546686
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate Programmed Death Ligand 1 Expression in Macrophages.
Liu J; Fan L; Yu H; Zhang J; He Y; Feng D; Wang F; Li X; Liu Q; Li Y; Guo Z; Gao B; Wei W; Wang H; Sun G
Hepatology; 2019 Jul; 70(1):241-258. PubMed ID: 30854665
[TBL] [Abstract][Full Text] [Related]
15. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
[TBL] [Abstract][Full Text] [Related]
16. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived exosomes promote macrophages M2 polarization through miR-1-3p and regulate the progression of liver cancer.
Gu W; Yang Y; Liu J; Xue J; Zhao H; Mao L; Zhao S
Mol Immunol; 2023 Oct; 162():64-73. PubMed ID: 37657187
[TBL] [Abstract][Full Text] [Related]
18. Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth.
Wu P; Zhao L; Kong G; Song B
Technol Cancer Res Treat; 2024; 23():15330338241246649. PubMed ID: 38656249
[No Abstract] [Full Text] [Related]
19. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
20. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
